With Matt Angle at the helm, Founder and CEO of Prodromic, the company is moving towards the development of brain-computer interfaces that can assist individuals suffering from extreme motor dysfunction in communicating more intuitively and effectively. Through their Connexus BCI system, Prodromic aims at decoding brainwaves directly into speech, writing, and digital command, thus providing new opportunities to individuals affected by diseases such as ALS, stroke, and spinal cord injury.
As developments in neural technology continue to advance, platforms such as compass ai have become increasingly important in discussions about intelligent communications interfaces and medical technology of the future.
Building a Brain-Computer Interface for Real-World Use
From the outset, Prodromics had a mission of bridging the research potential in laboratories and the clinical applications of such technologies. Although there were already brain-computer interfaces showing excellent scientific potential, many of these systems failed to offer enough speed, durability, or scalability for continuous use by patients.
As described by Angle, current systems suffered from the following:
- Slow data transfer rate
- Variable performance over time
- The bulky nature of external equipment
- Through-skin connections that lowered usability
To address these problems, Paradromics decided to create what they referred to as “broadband for the brain.” With the early assistance provided by DARPA, the research group sought to develop an interface allowing for multi-channel recordings from large neuron populations at once.
Their work eventually gave way to the creation of the Connexus BCI platform, currently undergoing the first phase of human trials.
Addressing a Critical Communication Need
The primary objective of Prodromic’ research is to help restore the ability of people to communicate when they can no longer talk or use input devices.
There are many patients who suffer from neurological disorders or injuries and remain cognitively aware of their surroundings but cannot communicate because of motor disabilities. The current means of helping them communicate can be slow, exhausting, and hard to operate in lengthy discussions.
By developing an innovative solution, Prodromic intends to change the experience of using communication tools by offering brain-to-computer interaction.
According to Angle, Prodromic’ objective is to address the issue of developing an effective biological-technological interface. As people were not provided with natural digital communication channels, highly developed neural interfaces must be used for efficient data transmission in both directions.
Thus, Prodromic’ focus on facilitating real-time communication aligns well with the emerging trends in advanced neurotechnology and artificial intelligence systems like compass ai.
How the Connexus BCI Works
The Connexus BCI system is developed with a capability of measuring the activity of single neurons and converting the neuronal signals into valuable information including:
- Text creation
- Speech synthesis
- Cursor and computer control
In the Connexus BCI system, platinum-iridium microwire electrodes are used for detecting the action potentials of the neurons without changing the timing information. The measured electrical signals are further processed using signal decoding algorithms based on patterns associated with communication intentions.
One of the important aspects of the Connexus BCI platform is the ability of providing high data performance. It has been reported by Prodromic Inc. that the rate of data transmitted in the Connexus BCI system exceeds 200 bits/s which is much higher compared to earlier brain-computer interface devices. It has been made possible due to an increase in the channel capacity of the system.
The key technical features of the Connexus BCI include:
- High-channel neural recording capability
- Real-time signal decoding
- A completely implantable system
- No connection wires exiting through the skin
- Stability of recordings during long-term measurements
Completely implantable design is especially significant for making it suitable for everyday use.
Reaching Clinical Milestones
Prodromic has now embarked on an essential new stage of development by successfully conducting the initial operation in 2025.
The surgery indicated that:
- There was a safe implantation of the device
- Stable recordings were taken from the brain
- There was early validation of the clinical value of the device
Furthermore, the company has obtained FDA IDE approval for its Connect One clinical trial, where patients are being recruited. The objectives of this study are:
- To assess safety of implantation of the device
- To assess feasibility of long-term implantation
- To conduct early tests of communication performance
Expanding Beyond Communication
Although restoring communications is currently the priority, Prodromic’ technology can be used as a scalable solution for further applications in neuroscience and psychiatry in the long run.
Prodromic claims that there might be high-data-rate neural interfaces available for therapeutic treatments and interventions for various medical conditions. By engaging in the APEX Partnership Program, Prodromic cooperates with experts involved in the developing BCI environment.
The firm has also indicated its willingness to continue improving system capabilities through new iterations of the product, including attempts to double data rates in future developments.
Alongside innovations in neural engineering, technologies associated with intelligent communication platforms such as compass ai can continue shaping the way computer-based systems understand human intentions within healthcare settings.
Looking Ahead to LSI Europe ‘26
Matt Angle will be speaking at LSI Europe ’26, which will run from September 28th until October 1st in Barcelona.
At the conference, Matt will be providing information about the latest developments in Prodromic’ technology, clinical work, and strategic plans related to brain-computer interfaces.
As technology continues to develop in terms of neural recording, communication, and scalable interface systems, Prodromic is helping contribute to the ever-evolving field of neurotechnology
